tiprankstipranks
Oramed Pharmaceuticals (ORMP)
NASDAQ:ORMP
Holding ORMP?
Track your performance easily

Oramed Pharm (ORMP) Financial Statements

511 Followers

Oramed Pharm Financial Overview

Oramed Pharm's market cap is currently ―. The company's EPS TTM is $0.109; its P/E ratio is 21.19; Oramed Pharm is scheduled to report earnings on July 10, 2024, and the estimated EPS forecast is $0.01. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -18.51M$ 11.10M$ 2.13M$ 14.51M$ -2.46M
EBITDA$ -18.46M$ 11.15M$ 2.18M$ 14.56M$ -2.40M
Net Income Common Stockholders$ -19.62M$ 9.21M$ 1.54M$ 13.34M$ -3.22M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 99.56M$ 150.96M$ 96.31M$ 66.77M$ 5.47M
Total Assets$ 165.08M$ 184.22M$ 203.65M$ 220.55M$ 230.89M
Total Debt$ 464.00K$ 486.00K$ 32.56M$ 51.95M$ 76.00M
Net Debt$ -99.09M$ -150.47M$ -63.75M$ -14.82M$ 70.53M
Total Liabilities$ 9.56M$ 8.07M$ 37.93M$ 57.66M$ 82.66M
Stockholders Equity$ 156.44M$ 177.06M$ 166.64M$ 163.82M$ 149.13M
Cash Flow-
Free Cash Flow$ -7.11M$ 2.08M$ -1.48M$ -1.42M$ -726.00K
Operating Cash Flow$ -7.10M$ 2.08M$ -1.48M$ -1.42M$ -694.00K
Investing Cash Flow$ -34.26M$ 94.66M$ 30.00M$ 30.00M$ -75.12M
Financing Cash Flow$ -1.29M$ -30.55M$ -19.00M$ -25.00M$ 74.55M
Currency in USD

Oramed Pharm Earnings and Revenue History

Oramed Pharm Debt to Assets

Oramed Pharm Cash Flow

Oramed Pharm Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis